Nuclear Medicine/Radiopharmaceuticals Market Size, Share, Trends, Growth and Forecast 2025

Nuclear Medicine/Radiopharmaceuticals Market

Nuclear Medicine/Radiopharmaceuticals Market by Type (Therapeutic and Diagnostic), Procedures (Cardiovascular, Oncology, Central Nervous System, Skeletal, Endocrine, Gastrointestinal, Pulmonary, and Others), Application (Cardiology, Oncology, Thyroid, Neurology, and Others), and End User (Research Institutes, Hospitals, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4797 Published Date: Sep-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 5.82 Billion USD 14.11 Billion 13.6% 2018

Nuclear Medicine/Radiopharmaceuticals Market

Nuclear Medicine/Radiopharmaceuticals Market: Overview

According to the report, global demand for nuclear medicine/ radiopharmaceuticals market was valued at approximately USD 5.82 Billion in 2018, and is expected to generate revenue of around USD 14.11 Billion by end of 2025, growing at a CAGR of around 13.6% between 2018 and 2025.

The report covers forecasts and analysis for the nuclear medicine/radiopharmaceuticals market on a global and regional level. The study provides historic data from 2016 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the nuclear medicine/ radiopharmaceuticals market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the nuclear medicine/ radiopharmaceuticals market on a global as well as regional level.

Global Nuclear Medicine/Radiopharmaceuticals Market SizeRequest Free Sample

In order to give the users of this report a comprehensive view of the nuclear medicine/radiopharmaceuticals market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product and services segment is benchmarked based on their market size, growth rate, and general attractiveness.

The report provides a company market share analysis in order to give a broader overview of the key players in the nuclear medicine/ radiopharmaceuticals market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the nuclear medicine/radiopharmaceuticals market on a global and regional basis.

Nuclear medicine is a medical stream that uses radioactive substances for the diagnosis and treatment of diseases. Radiopharmaceuticals used in nuclear medicine are radioactive compounds provided to the patient, and observed via particular imaging devices, for therapeutic and diagnostic purposes. SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) scans are the two most widely used imaging modalities in nuclear medicine.

Factors such as a rise in cases of cancer and other target conditions targeted cancer treatment with the help of alpha radioimmunotherapy, initiatives to bridge the demand-supply gap of Mo-99, convenience of treatment, implementation of clear imaging procedure, and technological advancements will act as major driving factors in the growth of global nuclear medicine/ radiopharmaceuticals market. The application of radiopharmaceuticals in neurology and favorable government policies in developing regions will act as an opportunity for the market players in the nuclear medicine/radiopharmaceutical market. Nonetheless, the short half-life of radiopharmaceuticals, shortage in supply, difficulties in logistics, dearth of skilled personnel, and lack of awareness in low-income countries will restrict the growth of the global nuclear medicine/ radiopharmaceuticals market.

Global Nuclear Medicine/Radiopharmaceuticals Market: Segmentation

The global nuclear medicine/radiopharmaceuticals market has been split into type, procedures, application, end user, and region. Based on type, the nuclear medicine/ radiopharmaceuticals market has been segmented into therapeutic and diagnostic. The diagnostic segment accounted for the highest market share in 2018 due to the growing patient population, rising awareness regarding the use of nuclear medicine, and availability of new radioisotopes. The therapeutic segment has been divided into alpha emitters, beta emitters, and brachytherapy isotopes. The diagnostic segment has been divided into PET radiopharmaceuticals and SPECT radiopharmaceuticals. The procedures segment has been segmented into cardiovascular, oncology, central nervous system, skeletal, endocrine, gastrointestinal, pulmonary, and others. The application segment has been segmented into cardiology, oncology, thyroid, neurology, and others. The oncology segment accounted for the highest market share in 2018 due to an increase in the number of cancer cases and use of the F-18 isotope. The end user segment has been segmented into research institutes, hospitals, diagnostic centers, and others.

Global Nuclear Medicine/Radiopharmaceuticals Market: Regional Analysis

North America will be the leading region during the forecast period. The development of unique technologies for the production of isotopes, the presence of leading market players, and the rapid uptake of new technologies will boost market growth in this region. Europe will be the second largest market. The major reasons are the presence of skilled professionals, a rise in awareness regarding the use of nuclear medicine, high cancer prevalence, and favorable reimbursement scenario. The Asia Pacific will propagate at a speedy rate over the forecast period due to rapid technological updation in the healthcare sector and increasing cases of cancer and other chronic ailments. The Latin American market will develop at a significant rate during the forecast period. The African and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

Nuclear Medicine/Radiopharmaceuticals Market: Report Scope

Report Attributes Report Details
Report Name Nuclear Medicine/Radiopharmaceuticals Market Size Report
Market Size in 2018 USD 5.82 Billion
Market Forecast in 2025 USD 14.11 Billion
Growth Rate CAGR of 13.6%
Number of Pages 188
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered GE Healthcare, Curium, Cardinal Health, Bayer, Advanced Accelerator Applications, Lantheus Medical Imaging, and Jubilant Life Sciences among others.
Segments Covered By Product, By Procedures, By Application And By Region.
Base Year 2018
Historical Year 2015 to 2018
Forecast Year 2019 - 2025
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Lambda Cyhalothrin Market: Competitive Players

The report also includes detailed profiles of key players such as:

  • GE Healthcare
  • Curium
  • Cardinal Health
  • Bayer
  • Advanced Accelerator Applications
  • Lantheus Medical Imaging
  • and Jubilant Life Sciences among others.

This report segments the Global Nuclear Medicine/Radiopharmaceuticals Market as follows:

Global Nuclear Medicine/Radiopharmaceuticals Market: By Type

  • Therapeutic
  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy Isotopes
  • Diagnostic
  • PET Radiopharmaceuticals
  • SPECT Radiopharmaceuticals

Global Nuclear Medicine/Radiopharmaceuticals Market: By Procedures

  • Cardiovascular
  • Oncology
  • Central Nervous System
  • Skeletal
  • Endocrine
  • Gastrointestinal
  • Pulmonary
  • Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By Application

  • Cardiology
  • Oncology
  • Thyroid
  • Neurology
  • Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By End User

  • Research Institutes
  • Hospitals
  • Diagnostic Centers
  • Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Nuclear medicine/ radiopharmaceuticals market was valued at approximately USD 5.82 Billion in 2018, and is expected to generate revenue of around USD 14.11 Billion by end of 2025

The report also includes detailed profiles of key players such as GE Healthcare, Curium, Cardinal Health, Bayer, Advanced Accelerator Applications, Lantheus Medical Imaging, and Jubilant Life Sciences among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed